These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 36003146)
1. Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma. Xue S; Ge W; Wang K; Mao T; Zhang X; Xu H; Wang Y; Yao J; Li S; Yue M; Ma J; Wang Y; Shentu D; Cui J; Wang L Front Cell Dev Biol; 2022; 10():942225. PubMed ID: 36003146 [TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma. Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324 [TBL] [Abstract][Full Text] [Related]
3. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma. Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma. Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823 [No Abstract] [Full Text] [Related]
5. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. Yan C; Niu Y; Li F; Zhao W; Ma L J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146 [TBL] [Abstract][Full Text] [Related]
6. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms. Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D Front Genet; 2021; 12():692953. PubMed ID: 34490033 [No Abstract] [Full Text] [Related]
7. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma. Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802 [TBL] [Abstract][Full Text] [Related]
8. Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma. Zhang Q; Lv L; Ma P; Zhang Y; Deng J; Zhang Y Front Immunol; 2021; 12():743938. PubMed ID: 34956177 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Wang Y; Song F; Zhang X; Yang C Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359 [TBL] [Abstract][Full Text] [Related]
10. Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases. Mao M; Ling H; Lin Y; Chen Y; Xu B; Zheng R Front Genet; 2021; 12():702102. PubMed ID: 34335699 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial energy metabolism-related gene signature as a prognostic indicator for pancreatic adenocarcinoma. Ma Y; Tang R; Huang P; Li D; Liao M; Gao S Front Pharmacol; 2024; 15():1332042. PubMed ID: 38572434 [No Abstract] [Full Text] [Related]
12. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma. Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576 [TBL] [Abstract][Full Text] [Related]
13. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma. Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M Front Genet; 2022; 13():989719. PubMed ID: 36212154 [No Abstract] [Full Text] [Related]
14. A panel of necroptosis-related genes predicts the prognosis of pancreatic adenocarcinoma. Luo Z; Wang L; Shang Z; Guo Q; Liu Q; Zhang M; Li T; Wang Y; Zhang Y; Zhang Y; Zhang X Transl Oncol; 2022 Aug; 22():101462. PubMed ID: 35635957 [TBL] [Abstract][Full Text] [Related]
15. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma. Huang Q; Peng X; Li Q; Zhu J; Xue J; Jiang H Front Immunol; 2023; 14():1111494. PubMed ID: 36817451 [TBL] [Abstract][Full Text] [Related]
16. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma. Li J; Yin J; Li W; Wang H; Ni B Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100 [TBL] [Abstract][Full Text] [Related]
17. Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer. Sun Y; Wang X; Yao L; He R; Man C; Fan Y Front Oncol; 2024; 14():1246308. PubMed ID: 38375157 [TBL] [Abstract][Full Text] [Related]
18. Construction and evaluation of an aging-associated genes-based model for pancreatic adenocarcinoma prognosis and therapies. Zhao J; Guan K; Xing J Int J Immunopathol Pharmacol; 2023; 37():3946320231172072. PubMed ID: 37072128 [No Abstract] [Full Text] [Related]
19. Determination of a DNA repair-related gene signature with potential implications for prognosis and therapeutic response in pancreatic adenocarcinoma. Lai J; Chen W; Zhao A; Huang J Front Oncol; 2022; 12():939891. PubMed ID: 36353555 [TBL] [Abstract][Full Text] [Related]
20. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer. Wu M; Li X; Zhang T; Liu Z; Zhao Y Front Oncol; 2019; 9():996. PubMed ID: 31612115 [No Abstract] [Full Text] [Related] [Next] [New Search]